Greg Kunst

Greg is presently Senior Director of Global Market Access and Business Development at Glaukos Corporation (NYSE: GKOS), an innovative micro-invasive glaucoma device and drug delivery company based in San Clemente, CA. Greg is responsible for the global market access, reimbursement, health economics and outcomes research, government affairs, and business development teams at Glaukos. Previous to Glaukos, Greg worked at Alcon, a Novartis Company, as a Global Franchise Director over the Alcon glaucoma surgery and retina pharmaceutical businesses. Before coming to Alcon, Greg work in various areas of continuing responsibility at Kinetic Concepts, Inc. (Acelity Inc.) including as a Global Market Access Director, Head of Market Access and Health Economics, Asia & Latin America, and Global Health Economics Manager. Greg received a Master’s in Business Administration degree from Vanderbilt University and a Bachelor’s of Science degree in Economics from Brigham Young University.